Development of a Minimally Invasive Seizure Gauge

Seer Medical

Status: Completed

Conditions: Epilepsy

Treatments: Device: EpiTel Epilog; Device: Empatica E4; Device: GENEActiv

Study type: Interventional

Funder types: Industry

Identifiers

NCT03882671

HREC042_18

Details and patient eligibility

About

The researchers are trying to assess changes in physiological signals before and during seizures.

Full description

Subjects that are undergoing video EEG monitoring in their home for their epilepsy at Seer Medical will be consented to participate in this study for a minimum of two days and/or the duration of their monitoring period for their clinical care. Subjects will be asked to wear up to 4 different commercially available seizure detection devices and complete surveys.

When the subjects clinical EEG monitoring is completed data scientists will analyze the data to identify patterns.

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with epilepsy undergoing scalp EEG for clinical care, or an implanted device capable of monitoring brain activity and identifying seizures
• Patients of age 18 or above

Exclusion criteria

• Cognitive or psychiatric condition rendering patient unable to cooperate with data collection, or manage and recharge smart watch and tablet computer devices.

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

40 participants in 1 patient group

Monitoring Device

Experimental group

Description:

Subjects will be asked to wear up to 3 different noninvasive seizure detection devices including EpiTel EpiLog, Empatica E4, GeneActiv

Treatment:

Device: GENEActiv

Device: Empatica E4

Device: EpiTel Epilog